Moxetumomab pasudotox and Prolixin Decanoate
Determining the interaction of Moxetumomab pasudotox and Prolixin Decanoate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: fluphenazine
Brand name: Permitil, Prolixin, Prolixin Decanoate, Prolixin Enanthate
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Prolixin Oral Concentrate
- Moxetumomab pasudotox-Proloprim
- Moxetumomab pasudotox-Promacot
- Moxetumomab pasudotox-Promacot Injection, Intravenous
- Moxetumomab pasudotox-Promacta
- Moxetumomab pasudotox-Promacta (Eltrombopag Powder for Suspension)
- Prolixin Decanoate-Moxetumomab Pasudotox-tdfk
- Prolixin Decanoate-Moxetumomab pasudotox-tdfk Intravenous
- Prolixin Decanoate-Moxifloxacin
- Prolixin Decanoate-Moxifloxacin (Systemic)
- Prolixin Decanoate-Moxifloxacin Hydrochloride
- Prolixin Decanoate-Moxifloxacin Injection